Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Obesity-associated breast inflammation among Hispanic/Latina breast cancer patients.

Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA, Hershman DL, Dannenberg AJ, Iyengar NM.

Cancer Prev Res (Phila). 2018 Nov 7. pii: canprevres.0207.2018. doi: 10.1158/1940-6207.CAPR-18-0207. [Epub ahead of print]

PMID:
30404870
2.

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; and I-SPY 2 Investigators.

NPJ Breast Cancer. 2018 Aug 17;4:26. doi: 10.1038/s41523-018-0074-6. eCollection 2018. Review.

3.

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.

Kalinsky K, Sparano JA, Zhong X, Andreopoulou E, Taback B, Wiechmann L, Feldman SM, Ananthakrishnan P, Ahmad A, Cremers S, Sireci AN, Cross JR, Marks DK, Mundi P, Connolly E, Crew KD, Maurer MA, Hibshoosh H, Lee S, Hershman DL.

Clin Transl Oncol. 2018 May 7. doi: 10.1007/s12094-018-1888-2. [Epub ahead of print]

PMID:
29736694
4.

Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer.

Gunther JE, Lim EA, Kim HK, Flexman M, Altoé M, Campbell JA, Hibshoosh H, Crew KD, Kalinsky K, Hershman DL, Hielscher AH.

Radiology. 2018 Jun;287(3):778-786. doi: 10.1148/radiol.2018161041. Epub 2018 Feb 12.

PMID:
29431574
5.

Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.

Chua CW, Epsi NJ, Leung EY, Xuan S, Lei M, Li BI, Bergren SK, Hibshoosh H, Mitrofanova A, Shen MM.

Elife. 2018 Jan 15;7. pii: e28768. doi: 10.7554/eLife.28768.

6.

The unusual suspects: A review of unusual benign and malignant male breast imaging cases.

Mango VL, Goodman S, Clarkin K, Wynn RT, Friedlander L, Hibshoosh H, Ha R.

Clin Imaging. 2018 Jul - Aug;50:78-85. doi: 10.1016/j.clinimag.2017.12.012. Epub 2017 Dec 28.

PMID:
29328960
7.

Optical Coherence Tomography: A Novel Imaging Method for Post-lumpectomy Breast Margin Assessment-A Multi-reader Study.

Ha R, Friedlander LC, Hibshoosh H, Hendon C, Feldman S, Ahn S, Schmidt H, Akens MK, Fitzmaurice M, Wilson BC, Mango VL.

Acad Radiol. 2018 Mar;25(3):279-287. doi: 10.1016/j.acra.2017.09.018. Epub 2017 Nov 23.

PMID:
29174226
8.

Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis.

Liu YL, Choi C, Lee SM, Zhong X, Hibshoosh H, Kalinsky K, Connolly EP.

Clin Breast Cancer. 2018 Apr;18(2):114-120. doi: 10.1016/j.clbc.2017.06.006. Epub 2017 Jun 23.

PMID:
28720418
9.

p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.

Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson S, Hibshoosh H, Manfredi J, Rabadan R, Parsons R.

Mol Cancer Res. 2017 Aug;15(8):1051-1062. doi: 10.1158/1541-7786.MCR-17-0089. Epub 2017 May 8.

10.

Comparative study of texture features in OCT images at different scales for human breast tissue classification.

Yu Gan, Xinwen Yao, Chang E, Bin Amir S, Hibshoosh H, Feldman S, Hendon CP.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3926-3929. doi: 10.1109/EMBC.2016.7591586.

11.

Visualization and tissue classification of human breast cancer images using ultrahigh-resolution OCT.

Yao X, Gan Y, Chang E, Hibshoosh H, Feldman S, Hendon C.

Lasers Surg Med. 2017 Mar;49(3):258-269. doi: 10.1002/lsm.22654. Epub 2017 Mar 6.

12.

Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.

McCullough LE, Chen J, Cho YH, Khankari NK, Bradshaw PT, White AJ, Teitelbaum SL, Terry MB, Neugut AI, Hibshoosh H, Santella RM, Gammon MD.

Breast Cancer Res. 2017 Feb 21;19(1):19. doi: 10.1186/s13058-017-0811-z.

13.

Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients.

Lim EA, Gunther JE, Kim HK, Flexman M, Hibshoosh H, Crew K, Taback B, Campbell J, Kalinsky K, Hielscher A, Hershman DL.

Breast Cancer Res Treat. 2017 Apr;162(3):533-540. doi: 10.1007/s10549-017-4150-7. Epub 2017 Feb 11.

PMID:
28190249
14.

DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.

Wu HC, Southey MC, Hibshoosh H, Santella RM, Terry MB.

Anticancer Res. 2017 Feb;37(2):659-664.

15.

Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.

Oberg JA, Glade Bender JL, Sulis ML, Pendrick D, Sireci AN, Hsiao SJ, Turk AT, Dela Cruz FS, Hibshoosh H, Remotti H, Zylber RJ, Pang J, Diolaiti D, Koval C, Andrews SJ, Garvin JH, Yamashiro DJ, Chung WK, Emerson SG, Nagy PL, Mansukhani MM, Kung AL.

Genome Med. 2016 Dec 23;8(1):133. doi: 10.1186/s13073-016-0389-6.

16.

Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study.

Consul N, Guo X, Coker C, Lopez-Pintado S, Hibshoosh H, Zhao B, Kalinsky K, Acharyya S.

Clin Med Insights Oncol. 2016 Sep 11;10:83-94. doi: 10.4137/CMO.S40479. eCollection 2016.

17.

Carcinoma en cuirasse caused by pleomorphic lobular carcinoma of the breast in a man.

Lauren CT, Antonov NK, McGee JS, de Vinck DC, Hibshoosh H, Grossman ME.

JAAD Case Rep. 2016 Aug 13;2(4):317-9. doi: 10.1016/j.jdcr.2016.06.006. eCollection 2016 Jul. No abstract available.

18.

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

She QB, Gruvberger-Saal SK, Maurer M, Chen Y, Jumppanen M, Su T, Dendy M, Lau YK, Memeo L, Horlings HM, van de Vijver MJ, Isola J, Hibshoosh H, Rosen N, Parsons R, Saal LH.

BMC Cancer. 2016 Aug 2;16:587. doi: 10.1186/s12885-016-2609-2.

19.

Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial.

Kalinsky K, Zheng T, Hibshoosh H, Du X, Mundi P, Yang J, Refice S, Feldman SM, Taback B, Connolly E, Crew KD, Maurer MA, Hershman DL.

Clin Transl Oncol. 2017 Feb;19(2):180-188. doi: 10.1007/s12094-016-1521-1. Epub 2016 Jun 15.

PMID:
27305912
20.

Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.

Liu YL, Saraf A, Lee SM, Zhong X, Hibshoosh H, Kalinsky K, Connolly EP.

Breast Cancer Res Treat. 2016 Jun;157(3):555-64. doi: 10.1007/s10549-016-3837-5. Epub 2016 May 25.

21.

Tumor characterization and treatment monitoring of postsurgical human breast specimens using harmonic motion imaging (HMI).

Han Y, Wang S, Hibshoosh H, Taback B, Konofagou E.

Breast Cancer Res. 2016 May 9;18(1):46. doi: 10.1186/s13058-016-0707-3.

22.

Cytomorphology of Recurrent Osseous Extracranial Meningioma of Right Pubic Ramus:: Report of a Case and Literature Review.

Bokhari A, Hibshoosh H, Tiscornia-Wasserman PG.

Diagn Cytopathol. 2016 Jul;44(7):618-22. doi: 10.1002/dc.23483. Epub 2016 Apr 15. Review.

PMID:
27079302
23.

DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.

McCullough LE, Chen J, Cho YH, Khankari NK, Bradshaw PT, White AJ, Garbowski G, Teitelbaum SL, Terry MB, Neugut AI, Hibshoosh H, Santella RM, Gammon MD.

Breast Cancer Res Treat. 2016 Feb;156(1):183-94. doi: 10.1007/s10549-016-3724-0. Epub 2016 Mar 5.

24.

Pubertal outcome in a female with virilizing adrenocortical carcinoma.

Breidbart E, Cameo T, Garvin JH, Hibshoosh H, Oberfield SE.

J Pediatr Endocrinol Metab. 2016 Apr;29(4):503-9. doi: 10.1515/jpem-2015-0123.

25.

Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer.

White AJ, Chen J, Teitelbaum SL, McCullough LE, Xu X, Hee Cho Y, Conway K, Beyea J, Stellman SD, Steck SE, Mordukhovich I, Eng SM, Beth Terry M, Engel LS, Hatch M, Neugut AI, Hibshoosh H, Santella RM, Gammon MD.

Environ Res. 2016 Feb;145:93-100. doi: 10.1016/j.envres.2015.11.033. Epub 2015 Dec 6.

26.

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ.

Cancer Prev Res (Phila). 2015 Dec;8(12):1131-7. doi: 10.1158/1940-6207.CAPR-14-0274-T. Epub 2015 Oct 15.

27.

Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.

White AJ, Chen J, McCullough LE, Xu X, Cho YH, Teitelbaum SL, Neugut AI, Terry MB, Hibshoosh H, Santella RM, Gammon MD.

Cancer Causes Control. 2015 Dec;26(12):1791-802. doi: 10.1007/s10552-015-0672-7. Epub 2015 Sep 25.

28.

PTEN and NEDD4 in Human Breast Carcinoma.

Chen Y, van de Vijver MJ, Hibshoosh H, Parsons R, Saal LH.

Pathol Oncol Res. 2016 Jan;22(1):41-7. doi: 10.1007/s12253-015-9971-2. Epub 2015 Aug 15.

29.

Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.

McCullough LE, Chen J, White AJ, Xu X, Cho YH, Bradshaw PT, Eng SM, Teitelbaum SL, Terry MB, Garbowski G, Neugut AI, Hibshoosh H, Santella RM, Gammon MD.

Int J Cancer Clin Res. 2015;2(1). pii: 013.

30.

Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women.

McCullough LE, Chen J, White AJ, Xu X, Cho YH, Bradshaw PT, Eng SM, Teitelbaum SL, Terry MB, Garbowski G, Neugut AI, Hibshoosh H, Santella RM, Gammon MD.

J Cancer. 2015 May 1;6(6):548-54. doi: 10.7150/jca.11359. eCollection 2015.

31.

Methylation Abnormalities in Mammary Carcinoma: The Methylation Suicide Hypothesis.

O'Donnell AH, Edwards JR, Rollins RA, Vander Kraats ND, Su T, Hibshoosh HH, Bestor TH.

J Cancer Ther. 2014 Dec 1;5(14):1311-1324.

32.

PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.

Mense SM, Barrows D, Hodakoski C, Steinbach N, Schoenfeld D, Su W, Hopkins BD, Su T, Fine B, Hibshoosh H, Parsons R.

Sci Signal. 2015 Mar 31;8(370):ra32. doi: 10.1126/scisignal.2005840.

33.

Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.

Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, Levine B.

EBioMedicine. 2015 Mar;2(3):255-263.

34.

Ferroptosis as a p53-mediated activity during tumour suppression.

Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W.

Nature. 2015 Apr 2;520(7545):57-62. doi: 10.1038/nature14344. Epub 2015 Mar 18.

35.

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients.

Baer LN, Savage DG, Hibshoosh HH, Kalinsky K.

Clin Sarcoma Res. 2014 Oct 31;4(1):15. doi: 10.1186/2045-3329-4-15. eCollection 2014.

36.

Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer.

Kalinsky K, Lim EA, Andreopoulou E, Desai AM, Jin Z, Tu Y, Hibshoosh H, Wang A, Greenlee H, Crew KD, Maurer M, Sparano JA, Hershman DL.

Cancer Invest. 2014 Nov;32(9):439-44. doi: 10.3109/07357907.2014.958232. Epub 2014 Sep 25.

37.

Single luminal epithelial progenitors can generate prostate organoids in culture.

Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, Badani KK, McKiernan JM, Benson MC, Hibshoosh H, Shen MM.

Nat Cell Biol. 2014 Oct;16(10):951-61, 1-4. doi: 10.1038/ncb3047. Epub 2014 Sep 21.

38.

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.

Li G, Wang X, Hibshoosh H, Jin C, Halmos B.

PLoS One. 2014 Sep 19;9(9):e106349. doi: 10.1371/journal.pone.0106349. eCollection 2014.

39.

Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer.

Kalinsky K, Crew KD, Refice S, Xiao T, Wang A, Feldman SM, Taback B, Ahmad A, Cremers S, Hibshoosh H, Maurer M, Hershman DL.

Cancer Invest. 2014 May;32(4):150-7. doi: 10.3109/07357907.2014.889706. Epub 2014 Mar 7.

40.

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry.

Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB.

Br J Cancer. 2014 Mar 4;110(5):1367-77. doi: 10.1038/bjc.2013.807. Epub 2014 Feb 18.

41.

FDG PET/CT findings in a rare case of giant fibrovascular polyp of the esophagus harboring atypical lipomatous tumor/well-differentiated liposarcoma.

Beylergil V, Simmons MZ, Ulaner G, Jurcic J, Hibshoosh H, Carrasquillo JA.

Clin Nucl Med. 2014 Mar;39(3):288-91. doi: 10.1097/RLU.0000000000000358.

PMID:
24458178
42.

A secreted PTEN phosphatase that enters cells to alter signaling and survival.

Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J, Pappas K, Yu JS, Hodakoski C, Mense S, Klein J, Pegno S, Sulis ML, Goldstein H, Amendolara B, Lei L, Maurer M, Bruce J, Canoll P, Hibshoosh H, Parsons R.

Science. 2013 Jul 26;341(6144):399-402. doi: 10.1126/science.1234907. Epub 2013 Jun 6.

43.

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL.

Cancer Prev Res (Phila). 2012 Sep;5(9):1144-54. doi: 10.1158/1940-6207.CAPR-12-0117. Epub 2012 Jul 24.

44.

Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry.

Work ME, Andrulis IL, John EM, Hopper JL, Liao Y, Zhang FF, Knight JA, West DW, Milne RL, Giles GG, Longacre TA, O'Malley F, Mulligan AM, Southey MC, Hibshoosh H, Terry MB.

Breast Cancer Res Treat. 2012 Aug;134(3):1209-20. doi: 10.1007/s10549-012-2056-y. Epub 2012 Apr 25.

45.

MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience.

Espinel CF, Keating S, Hibshoosh H, Taback B, Joseph KA, El-Tamer M, Feldman S.

Scientifica (Cairo). 2012;2012:942507. doi: 10.6064/2012/942507. Epub 2012 Dec 31.

46.

The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study.

Xu X, Gammon MD, Jefferson E, Zhang Y, Cho YH, Wetmur JG, Teitelbaum SL, Bradshaw PT, Terry MB, Garbowski G, Hibshoosh H, Neugut AI, Santella RM, Chen J.

Epigenetics. 2011 Nov;6(11):1276-83. doi: 10.4161/epi.6.11.17744. Epub 2011 Nov 1.

47.

PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.

Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K.

Am J Surg Pathol. 2011 Oct;35(10):1473-83. doi: 10.1097/PAS.0b013e318227e2ee.

PMID:
21934480
48.

Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.

Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, Xu X, Bradshaw PT, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM.

Breast Cancer Res Treat. 2012 Jan;131(1):197-205. doi: 10.1007/s10549-011-1712-y. Epub 2011 Aug 12.

49.

Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns.

Edwards JR, O'Donnell AH, Rollins RA, Peckham HE, Lee C, Milekic MH, Chanrion B, Fu Y, Su T, Hibshoosh H, Gingrich JA, Haghighi F, Nutter R, Bestor TH.

Genome Res. 2010 Jul;20(7):972-80. doi: 10.1101/gr.101535.109. Epub 2010 May 20.

50.

Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors.

Mordukhovich I, Rossner P Jr, Terry MB, Santella R, Zhang YJ, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Gaudet MM, Steck SE, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Conway-Dorsey K, Gammon MD.

Environ Health Perspect. 2010 Apr;118(4):511-8. doi: 10.1289/ehp.0901233. Epub 2009 Nov 18.

Supplemental Content

Loading ...
Support Center